RA Medical Systems Performance
The firm owns a Beta (Systematic Risk) of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and RA Medical are completely uncorrelated.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days RA Medical Systems has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, RA Medical is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
Begin Period Cash Flow | 15 M |
RMED |
RA Medical Relative Risk vs. Return Landscape
If you would invest (100.00) in RA Medical Systems on April 24, 2025 and sell it today you would earn a total of 100.00 from holding RA Medical Systems or generate -100.0% return on investment over 90 days. RA Medical Systems is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than RMED, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
Risk |
RA Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for RA Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as RA Medical Systems, and traders can use it to determine the average amount a RA Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
RMED |
Based on monthly moving average RA Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of RA Medical by adding RA Medical to a well-diversified portfolio.
RA Medical Fundamentals Growth
RMED Stock prices reflect investors' perceptions of the future prospects and financial health of RA Medical, and RA Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on RMED Stock performance.
Return On Equity | -3.25 | |||
Return On Asset | -0.48 | |||
Operating Margin | (307.60) % | |||
Current Valuation | (8.89 M) | |||
Shares Outstanding | 6.46 M | |||
Price To Book | 0.86 X | |||
Price To Sales | 604.06 X | |||
Revenue | 14 K | |||
EBITDA | (18.2 M) | |||
Cash And Equivalents | 13.66 M | |||
Cash Per Share | 9.60 X | |||
Total Debt | 124.17 K | |||
Debt To Equity | 0.16 % | |||
Book Value Per Share | 6.81 X | |||
Cash Flow From Operations | (22.57 M) | |||
Earnings Per Share | (35.78) X | |||
Total Asset | 16.84 M | |||
Retained Earnings | (205.14 M) | |||
Things to note about RA Medical Systems performance evaluation
Checking the ongoing alerts about RA Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for RA Medical Systems help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.RA Medical Systems is not yet fully synchronised with the market data | |
RA Medical Systems has some characteristics of a very speculative penny stock | |
RA Medical Systems has a very high chance of going through financial distress in the upcoming years | |
The company reported the previous year's revenue of 14 K. Net Loss for the year was (26.86 M) with loss before overhead, payroll, taxes, and interest of (1.54 M). | |
RA Medical Systems currently holds about 13.66 M in cash with (22.57 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.6. | |
Roughly 37.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing RA Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether RA Medical's stock is overvalued or undervalued compared to its peers.
- Examining RA Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating RA Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of RA Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of RA Medical's stock. These opinions can provide insight into RA Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in RMED Stock
If you are still planning to invest in RA Medical Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RA Medical's history and understand the potential risks before investing.
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |